[PPARgamma and thiazolidinediones, something more than a treatment for diabetes].
Medina
G
G
Department of Medicine and Clinical Biochemistry. Addenbrooke's Hospital. University of Cambridge. Cambridge CB2 2QR, UK.
Sewter
C
C
Puig
A J
AJ
D001161:Arteriosclerosis / Q000378:metabolism; D002454:Cell Differentiation; D002471:Cell Transformation, Neoplastic; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000378:metabolism; D007004:Hypoglycemic Agents; D008024:Ligands; D008297:Male; D011085:Polycystic Ovary Syndrome / Q000378:metabolism; D020033:Protein Isoforms; D018160:Receptors, Cytoplasmic and Nuclear / Q000502:physiology; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones; D014157:Transcription Factors / Q000502:physiology
D007004:Hypoglycemic Agents; D008024:Ligands; D020033:Protein Isoforms; D018160:Receptors, Cytoplasmic and Nuclear; D013844:Thiazoles; D045162:Thiazolidinediones; D014157:Transcription Factors; C089946:2,4-thiazolidinedione